Vertex Pharmaceuticals (VRTX) EBT (2009 - 2026)

Vertex Pharmaceuticals' (VRTX) quarterly EBT came in at $1.3 billion in Q1 2026, up 71.54% year-on-year from $730.4 million in Q1 2025, and down 5.87% quarter-over-quarter from $1.3 billion in Q4 2025.

Vertex Pharmaceuticals (VRTX) EBT (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals' EBT history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

  • On a quarterly basis, EBT rose 71.54% year-over-year to $1.3 billion in Q1 2026; TTM through Mar 2026 was $5.2 billion, a 1820.75% increase from a year earlier, with the FY2025 full-year figure at $4.6 billion, up 1768.49% from the prior year.
  • EBT fell to $1.3 billion in Q1 2026 per VRTX's latest filing, from $1.3 billion in the prior quarter.
  • Across five years, EBT topped out at $1.3 billion in Q4 2025 and bottomed at -$3.4 billion in Q2 2024.
  • The 5-year median for EBT is $1.2 billion (2023), against an average of $868.0 million.
  • Across the five-year window, EBT jumped 2417.65% in 2022 and slumped 391.97% in 2024, its largest moves.
  • Year by year, EBT stood at $1.1 billion in 2022, then grew by 6.58% to $1.1 billion in 2023, then slipped by 0.97% to $1.1 billion in 2024, then gained by 17.11% to $1.3 billion in 2025, then declined by 5.87% to $1.3 billion in 2026.
  • Per Business Quant, the three latest VRTX EBT figures stand at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -36.97 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.31 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 259.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.25 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 831.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 438.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 221.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.25 Bn
Dec 31, 2025 1.33 Bn
Sep 30, 2025 1.30 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 730.40 Mn
Dec 31, 2024 1.14 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 -3.39 Bn
Mar 31, 2024 1.28 Bn
Dec 31, 2023 1.15 Bn
Sep 30, 2023 1.18 Bn
Jun 30, 2023 1.16 Bn
Mar 31, 2023 891.50 Mn
Dec 31, 2022 1.08 Bn
Sep 30, 2022 1.18 Bn
Jun 30, 2022 1.02 Bn
Mar 31, 2022 954.80 Mn
Dec 31, 2021 870.90 Mn
Sep 30, 2021 1.08 Bn
Jun 30, 2021 -44.20 Mn